SCHEMBL4287778

SCHEMBL4287778

CC(=N)CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8295404 0.72
SCHEMBL26468 0.70
Iodide SCHEMBL3305833 0.70
SCHEMBL12559498 0.68
SCHEMBL2835744 0.67
SCHEMBL19721748 0.67
SCHEMBL408066 0.67
SCHEMBL20888882 0.67
SCHEMBL213373 0.67
SCHEMBL68956 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110669042-A Preparation method and application of phentriazine compound used as polyvinyl chloride light stabilizer 河南龙湖生物技术有限公司 2020-01-10 CN claimed
CN-110615801-A Preparation method and application of triazine compound with polyvinyl chloride light stabilization effect 河南龙湖生物技术有限公司 2019-12-27 CN claimed
CN-110669042-A Preparation method and application of phentriazine compound used as polyvinyl chloride light stabilizer 河南龙湖生物技术有限公司 2020-01-10 CN disclosed
CN-110615801-A Preparation method and application of triazine compound with polyvinyl chloride light stabilization effect 河南龙湖生物技术有限公司 2019-12-27 CN disclosed
US-20180221310-A1 METHOD OF TREATING CANCER WITH A COMBINATION OF BENZYLIDENEGUANIDINE DERIVATIVES AND CHEMOTHERAPEUTIC AGENT INFLECTIS BIOSCIENCE (FR) 2018-08-09 US disclosed
US-20170275249-A1 SMALL LIPOPEPTIDOMIMETIC INHIBITORS OF GHRELIN O-ACYL TRANSFERASE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2017-09-28 US disclosed
US-20170152220-A1 O-ALKYL-BENZYLIDENEGUANIDINE DERIVATIVES AND THERAPEUTIC USE FOR THE TREATMENT OF DISORDERS ASSOCIATED AN ACCUMULATION OF MISFOLDED PROTEINS INFLECTIS BIOSCIENCE (FR) 2017-06-01 US disclosed
WO-2016044138-A1 HISTONE DEMETHYLASE INHIBITORS Quanticel Pharmaceuticals, Inc. (US) 2016-03-24 WO disclosed
US-9133191-B2 Substituted triazine derivatives and use thereof as stimulators of soluble guanylate cyclase BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-09-15 US disclosed
US-9023849-B2 Substituted fused imidazoles and pyrazoles and use thereof BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-05-05 US disclosed
US-20150094308-A1 SUBSTITUTED TRIAZINE DERIVATIVES AND USE THEREOF AS STIMULATORS OF SOLUBLE GUANYLATE CYCLASE BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-04-02 US disclosed
WO-2010104406-A1 PRODRUG FORMS OF KINASE INHIBITORS AND THEIR USE IN THERAPY AUCKLAND UNISERVICES LIMITED (NZ) 2010-09-16 WO disclosed
WO-2010070244-A2 COMPOSITION INCLUDING AT LEAST ONE SOLID FATTY ALCOHOL, DYEING OR COLOUR-LIGHTENING METHOD IMPLEMENTING SAME AND DEVICES L'OREAL (FR) 2010-06-24 WO disclosed
EP-2198929-A1 Hair dye or lightening composition comprising a fatty substance and a cationic polymer, and use thereof L'OREAL (FR) 2010-06-23 EP disclosed
EP-2198843-A1 Lightening of human keratinic fibers with a anhydrous composition comprising a mixture of monoethanolamine/basic amine acid and kit L'OREAL (FR) 2010-06-23 EP disclosed
EP-2198928-A2 Composition comprising a fatty substance and a silicate, dyeing or lightening process using it and devices therefore L'OREAL (FR) 2010-06-23 EP disclosed
EP-1667770-B1 METHOD FOR THE PRODUCTION OF DERIVATIVES OF 4A,5,9,10,11,12-HEXAHYDROBENZOFURO [3A,3,2][ 2]- BENZAZEPINE SANOCHEMIA PHARMAZEUTIKA AG (AT) 2009-03-11 EP disclosed
US-7312235-B2 Benzamide inhibitors of factor Xa MILLENNIUM PHARMACEUTICALS, INC. (US) 2007-12-25 US disclosed
WO-2007127012-A1 ANTIFUNGAL AGENTS MERCK & CO., INC. (US) 2007-11-08 WO disclosed
WO-2007088999-A1 TRISUBSTITUTED AMINE COMPOUND MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-08-09 WO disclosed